The C-Terminus of Panusin, a Lobster β-Defensin, Is Crucial for Optimal Antimicrobial Activity and Serum Stability

β-defensins are one of the most abundant and studied families of antimicrobial peptides (AMPs). Because of their selective toxicity to bacterial membranes and a broad spectrum of microbicidal action, β-defensins are regarded as potential therapeutic agents. This work focuses on a β-defensin-like AMP from the spiny lobster Panulirus argus (hereafter referred to as panusin or PaD). This AMP is structurally related to mammalian defensins via the presence of an αβ domain stabilized by disulfide bonds. Previous studies of PaD suggest that its C-terminus (Ct_PaD) contains the main structural determinants of antibacterial activity. To confirm this hypothesis, we made synthetic versions of PaD and Ct_PaD to determine the influence of the C-terminus on antimicrobial activity, cytotoxicity, proteolytic stability, and 3D structure. After successful solid-phase synthesis and folding, antibacterial assays of both peptides showed truncated Ct_PaD to be more active than native PaD, confirming the role of the C-terminus in activity and suggesting that cationic residues in that region enhance binding to negatively charged membranes. On the other hand, neither PaD nor Ct_PaD were hemolytic or cytotoxic in human cells. Proteolysis in human serum was also studied, showing high (>24 h) t1/2 values for PaD and lower but still considerable for Ct_PaD, indicating that the missing native disulfide bond in Ct_PaD alters protease resistance, albeit not decisively. NMR-2D experiments in water agree with the results obtained by circular dichroism (CD), where in SDS micelles, CD showed both peptides adopting an increasingly ordered structure in a hydrophobic environment, in tune with their ability to perturb bacterial membrane systems. In conclusion, while the β-defensin features of PaD are confirmed as advantageous in terms of antimicrobial activity, toxicity, and protease stability, the results of the present work suggest that these same features are preserved, even enhanced, in the structurally simpler Ct_PaD, which must therefore be viewed as a valuable lead for the development of novel anti-infectives.

[1]  D. Pan,et al.  Advances in the stability challenges of bioactive peptides and improvement strategies , 2022, Current research in food science.

[2]  Daryl R. Williams,et al.  Strategies for Improving Peptide Stability and Delivery , 2022, Pharmaceuticals.

[3]  P. Grieco,et al.  Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs , 2022, International journal of molecular sciences.

[4]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[5]  David Andreu,et al.  The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization. , 2020, Angewandte Chemie.

[6]  M. Mahlapuu,et al.  Antimicrobial peptides as therapeutic agents: opportunities and challenges , 2020, Critical reviews in biotechnology.

[7]  P. Harvey,et al.  Synthesis, structure, and activity of the antifungal plant defensin PvD1. , 2020, Journal of medicinal chemistry.

[8]  Ines Greco,et al.  Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides , 2020, Scientific Reports.

[9]  G. Bonacucina,et al.  Surfactant Self-Assembling and Critical Micelle Concentration: One Approach Fits All? , 2020, Langmuir : the ACS journal of surfaces and colloids.

[10]  S. Gronow,et al.  Influence of disulfide bonds in human beta defensin-3 on its strain specific activity against Gram-negative bacteria. , 2020, Biochimica et biophysica acta. Biomembranes.

[11]  M. Jiménez,et al.  Effect of phosphorylation in the structural behavior of peptides derived from the intrinsically disordered C-terminal domain of Histone H1.0. , 2020, Chemistry.

[12]  G. Bou,et al.  Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases , 2020, Antibiotics.

[13]  D. Andreu,et al.  Structural determinants conferring unusual long life in human serum to rattlesnake‐derived antimicrobial peptide Ctn[15‐34] , 2019, Journal of peptide science : an official publication of the European Peptide Society.

[14]  M. Schaller,et al.  Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide , 2019, Scientific Reports.

[15]  M. Amerikova,et al.  Antimicrobial activity, mechanism of action, and methods for stabilisation of defensins as new therapeutic agents , 2019, Biotechnology & Biotechnological Equipment.

[16]  Hong Yang,et al.  Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability. , 2018, Current drug metabolism.

[17]  Muhammad Sohail Zafar,et al.  Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug. , 2018, Current pharmaceutical design.

[18]  O. Yamasaki,et al.  Two arginine residues in the COOH‐terminal of human β‐defensin‐3 constitute an essential motif for antimicrobial activity and IL‐6 production , 2017, Experimental dermatology.

[19]  G. Morelli,et al.  Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics , 2017, Molecules.

[20]  R. Hoffmann,et al.  Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum , 2017, PloS one.

[21]  J. Tytgat,et al.  Panusin represents a new family of &bgr;‐defensin‐like peptides in invertebrates , 2017, Developmental and comparative immunology.

[22]  Shicui Zhang,et al.  Identification of a novel antimicrobial peptide from amphioxus Branchiostoma japonicum by in silico and functional analyses , 2015, Scientific Reports.

[23]  M. Mura,et al.  The role of C-terminal amidation in the membrane interactions of the anionic antimicrobial peptide, maximin H5. , 2015, Biochimica et biophysica acta.

[24]  R. Kar,et al.  Membrane disruptive antimicrobial activities of human β-defensin-3 analogs. , 2015, European journal of medicinal chemistry.

[25]  Woonghee Lee,et al.  NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy , 2014, Bioinform..

[26]  A. Bax,et al.  Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks , 2013, Journal of Biomolecular NMR.

[27]  D. Craik,et al.  The α-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance , 2012, Amino Acids.

[28]  Yang Shen,et al.  Prediction of Xaa-Pro peptide bond conformation from sequence and chemical shifts , 2010, Journal of biomolecular NMR.

[29]  A. Schmidtchen,et al.  Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37 , 2008, Antimicrobial Agents and Chemotherapy.

[30]  H. G. Boman,et al.  Antibacterial peptides: basic facts and emerging concepts , 2003, Journal of internal medicine.

[31]  Dirk Labudde,et al.  A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on 13C chemical shift statistics , 2002, Journal of biomolecular NMR.

[32]  K. Rajarathnam,et al.  13C NMR chemical shifts can predict disulfide bond formation , 2000, Journal of biomolecular NMR.

[33]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[34]  K Wüthrich,et al.  Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances. , 1984, Journal of molecular biology.

[35]  Yang Shen,et al.  Protein structural information derived from NMR chemical shift with the neural network program TALOS-N. , 2015, Methods in molecular biology.

[36]  N. Greenfield Using circular dichroism spectra to estimate protein secondary structure , 2007, Nature Protocols.

[37]  M. T. Miranda,et al.  Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. , 2006, Biopolymers.

[38]  P. Güntert Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.

[39]  Jacek Lubkowski,et al.  Antimicrobial characterization of human beta-defensin 3 derivatives. , 2003, Antimicrobial agents and chemotherapy.

[40]  R D Appel,et al.  Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.